IngredientID 4970
3-o-[beta-d-glucuronopyranosyl-(1→2)-o-beta-d-glucuronopyranosyl]-24-hydroxyglabrolide
C43H62O17257
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Herb: 2Ingredient: 1Target: 2Links: 6
Arranging relationship network...
Record Fields
Scalar fields from the final ingredient record.
- Ingredient Id
- 4970
- Core Entity Id
- 8716
- Source Entity Count
- 1
- Preferred Name
- 3-o-[beta-d-glucuronopyranosyl-(1→2)-o-beta-d-glucuronopyranosyl]-24-hydroxyglabrolide
- Name En
- Pubchem Id
- Smiles Canonical
- Molecular Formula
- C43H62O17257
- Molecular Weight
- 850.4000
- Inchikey
- Inchi
- Isomeric Smiles
- Cas Id
- Ob Score
- Mol Logp
- Num H Donors
- Num H Acceptors
- Num Rotatable Bonds
- Drug Likeness
- Polar Surface Area
- Molecular Volume
- Alogp
Names
Preferred names, aliases, and source labels retained in the final schema.
Name
3-O-[-beta-D-Glucuronopyranosyl-(1->2)-O--beta-D-glucuronopyranos-yl]-24-hydroxyglabrolide
Role
preferred
Source
ETCM_v2
Preferred
Yes
Name
3-o-[beta-d-glucuronopyranosyl-(1→2)-o-beta-d-glucuronopyranosyl]-24-hydroxyglabrolide
Role
preferred
Source
HERB_v2
Preferred
Yes
Name
3-o-[beta-d-glucuronopyranosyl-(1→2)-o-beta-d-glucuronopyranosyl]-24-hydroxyglabrolide
Role
preferred
Source
itcmdb_public
Preferred
Yes
Aliases
Additional names normalized into the restored final schema.
3-O-[-beta-D-Glucuronopyranosyl-(1->2)-O--beta-D-glucuronopyranos-yl]-24-hydroxyglabrolide
Cross References
Trusted external identifiers retained for this final record.
Herb
HBIN009235
Tcmid
8763
Sym Map
SMIT15639
Etcm Ingredient
3-O-[-beta-D-Glucuronopyranosyl-(1->2)-O--beta-D-glucuronopyranos-yl]-24-hydroxyglabrolide
Itcmdb Generated
ITX-INGREDIENT-182FB7313654
Attributes
Merged source attributes and domain-specific metadata.
Molecular Weight
850.400
Molecular Formula
C43H62O17
Molecular Formula
C43H62O17257
Fda Maximum Daily Dose (Fdamdd)
0.026
Quantitative Estimate Of Drug Likeness（Qed）
0.138